Back to discover
Drug

Guanosine

Research stage
Emerging research

Also known as Guanine riboside, Guo, Guanosin, Guanosina.

1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Oxidative damage is the earliest event in Alzheimer disease.

Research2001-08-01Journal of neuropathology and experimental neurology

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Guanosine
Aliases & brands
Guanine ribosideGuoGuanosinGuanosina
RxNorm CUI
1591890
ChEMBL ID
CHEMBL375655
UNII
12133JR80S

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

Oxidative damage is the earliest event in Alzheimer disease.

Journal of neuropathology and experimental neurology · 2001 · 1,298 cites
Recent papers

Oxidative damage is the earliest event in Alzheimer disease.

Journal of neuropathology and experimental neurology · 2001 · 1,298 cites
Major research themes1
Oxidative Stress1
Journals, researchers & institutions
Top journals
  • Journal of neuropathology and experimental neurology1
Leading researchers
  • Aliev G1
  • Atwood CS1
  • Balraj EK1
  • Chiba S1
  • Ghanbari H1
  • Hirai K1
  • Jones PK1
  • Nunomura A1
Leading institutions
free-text, unnormalised
  • Institute of Pathology1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature